Global Microbiome Therapeutics Market Report 2015-2030 - Analysis, Technologies & Forecasts - Key Vendors: 4D Pharma, AOBiome, c-LECta - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Microbiome Therapeutics Market, 2015 - 2030" report to their offering.

The Microbiome Therapeutics Market, 2015-2030' report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. Imbalance in the natural microbiota are a known cause for many chronic diseases such as antibiotic associated diarrhoea (AAD), Clostridium difficile infections (CDI), irritable bowel syndrome (IBS), diabetes, Crohn's disease and ulcerative colitis.

Key Topics Covered:

  • The microbiome therapeutic pipeline in terms of phase of development, type of products and indications.
  • The epidemiology, patient population and available treatment plans for the potential therapeutic areas in this field.
  • Partnerships that have taken place in the recent past covering research and development collaborations, product development and commercialisation agreements, license agreements, acquisitions and other relevant agreements.
  • Various investments and grants received by companies focused in this area.

The study provides a detailed market forecast and opportunity analysis for the short-mid term (2015-2022) and long term (2022-2030). The research, analysis and insights presented in this report include potential sales of FMT therapies and drugs in late stages of development. Our opinions and insights, presented in this study, were influenced by several discussions we conducted with experts in this area.

Companies Mentioned Include:

  • 4D Pharma
  • AOBiome
  • APC Microbiome Institute
  • AbbVie
  • ActoGeniX
  • Admera Health
  • Advanced Technology Ventures
  • Advancing Bio
  • AgBiome
  • Assembly Biosciences
  • Avid Biotics
  • Whole Biome
  • World Gastroenterology Organisation (WGO)
  • World Health Organisation (WHO)
  • Wyss Institute
  • Xycrobe Therapeutics
  • Yakult Honsha
  • c-LECta

Report Structure:

1. Preface

2. Executive Summary

3. Introduction

4. Microbiome Therapeutics And Diagnostics: Market Landscape

5. Probiotic And Prebiotic Drugs

6. Key Therapeutic Areas

7. Venture Capital Interest

8. Recent Collaborations

9. Market Sizing And Opportunity Analysis

10. Company Profiles

11. Conclusion

12. Interview Transcripts

13. Appendix 1: Tabulated Data

14. Appendix 2: List Of Companies And Organisations

For more information visit http://www.researchandmarkets.com/research/r5gmtc/microbiome

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals